Anhedonia Behavioural Activation and Ketamine Therapy (AAKT): Shaping a Proposal With Patient and Public Involvement

Anhedonia Behavioural Activation and Ketamine Therapy (AAKT): Shaping a Proposal With Patient and Public Involvement

Aims: Ketamine and behavioural activation (BA) reduce levels of anhedonia in major depressive disorder (MDD), though neither resolves anhedonia. Combining these treatments could yield additive or even multiplicative benefits.

Saved in:
Bibliographic Details
Main Authors: Anya Borissova, Allan Young, Mitul Mehta, Tim Dalgleish, Camilla Nord
Format: Article
Language:English
Published: Cambridge University Press 2025-06-01
Series:BJPsych Open
Online Access:https://www.cambridge.org/core/product/identifier/S2056472425107916/type/journal_article
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items